Physician profile
Bora Gumustop
NPI 1386673424
$63,786.17
in general payments reported to CMS, 2019-2025
11 companies · $21K in 2025
The $21K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,125 · 2020: $17K · 2021: $25.57 · 2022: $9,977 · 2023: $5,583 · 2024: $1,437 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,145 · Food and Beverage: $2,486 · Travel and Lodging: $958 · Grant: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,850.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,145.00 |
| Food and Beverage | $2,486.01 |
| Travel and Lodging | $957.94 |
| Grant | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $62,309.56 | 2019-2025 | General - Therapies, Axios, Spyglass |
| Apollo Endosurgery US INC | $914.85 | 2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $150.33 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $120.61 | 2023 | Dupixent |
| Fujifilm Healthcare Americas Corporation | $83.46 | 2023 | Fujifilm |
| Lucid Diagnostics INC. | $62.65 | 2023-2025 | |
| Covidien LP | $55.83 | 2020 | |
| Evoendo, INC | $40.02 | 2023 | |
| Medtronic, INC. | $17.71 | 2023 | Bravo |
| Endogastric Solutions, INC | $16.31 | 2019 | |
| Janssen Biotech, INC. | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bora Gumustop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.